Clinical Trial: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Alzheimer's Disease
Study Type: INTERVENTIONAL
Official Title: A Phase IIa, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 50561 in Patients With Mild or Mod
Brief Summary:
This is a multi-center, Phase IIa, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy, safety of two doses of 50561 compared to placebo in participants diagnosed with mild to moderate Alzheimer's disease.
Read more